The results of our study build up evidence regarding the need to avoid hypoglycemia and be cautious regarding the use of insulin and other antidiabetic agents with hypoglycemic potential (e.g., sulfonylureas), particularly in patients with diabetes seeking tight glycemic control. The gene discussed is INS; the disease is diabetes mellitus.